SFCPR

ARCHIVE

SF Journal of Clinical Pharmacology and Research

Archived Issues

Volume V2 Issue 1

Published articles in this issue

Health Benefits of Plant-Derived Bioactive Secondary Metabolites as Dietary Constituents

Abstract: Plants are one of the most important sources of human nutrition and they also act as store house of important pharmaceuticals. Plant-derived bioactive compounds have long been used to treat diseases in traditional medicine. Plant biotechnology provides a blooming opportunity for improving the bioactive compounds in our food. This coupled with the emergence of concepts like nutritional therapy and phytotherapy makes us curious about understanding the health benefits of the bioactive compounds in our food.

Read Full Text View PDF

Is it Possible to Prevent Covid-19 by ACE Inhibitors?

Abstract: Outbreaks of emerging infectious diseases continue to challenge human health. The reported incidence of emerging and re-emerging zoonotic disease is increasing in many parts of the world [1]. In December of 2019, a novel coronavirus (SARS-CoV-2) crossed species barriers to infect humans [2] and was effectively transmitted from person to person, leading to a pneumonia outbreak first reported in Wuhan, China [3-5]. This virus causes coronavirus disease-19 (COVID-19) with

Read Full Text View PDF

Gout and Rheumatoid Arthritis: Available Options for Pharmacotherapy. Overview of World Data

Abstract: Due to adverse effects, old-age uricosuric medications have been withdrawn only to assisted treatment of gout. Their place was taken by Xanthine Oxidase (XOI) inhibitors as the first-choice medication. Although they are easier to monitor and free from many side effects, they have a limited spectrum of associations. New-generation uricosuric medications have been included in combination therapy with XOI. They can also be used alone in the case of patients with XOI

Read Full Text View PDF
← Back to Journal Home